LTFS
BLRX

Ladenburg Thalmann Financial Services’s BioLineRX BLRX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
3
– – ﹤0.01% 5327
2019
Q3 		$0 Hold
3
– – ﹤0.01% 5275
2019
Q2 		$1K Sell
3
-1
-25% -$224 ﹤0.01% 5076
2019
Q1 		$1K Hold
4
– – ﹤0.01% 5043
2018
Q4 		$1K Hold
4
– – ﹤0.01% 5006
2018
Q3 		$2K Buy
4
+1
+33% +$550 ﹤0.01% 4848
2018
Q2 		$2K Hold
3
– – ﹤0.01% 4839
2018
Q1 		$2K Sell
3
-12
-80% -$7.35K ﹤0.01% 4839
2017
Q4 		$9K Buy
15
+7
+88% +$4.61K ﹤0.01% 4223
2017
Q3 		$6K Hold
8
– – ﹤0.01% 4307
2017
Q2 		$4K Hold
8
– – ﹤0.01% 4373
2017
Q1 		$5K Hold
8
– – ﹤0.01% 4285
2016
Q4 		$5K Sell
8
-59
-88% -$36.7K ﹤0.01% 4208
2016
Q3 		$46K Hold
67
– – ﹤0.01% 2836
2016
Q2 		$32K Hold
67
– – ﹤0.01% 3011
2016
Q1 		$41K Buy
67
+9
+16% +$5.65K ﹤0.01% 2734
2015
Q4 		$46K Buy
+58
New +$48.1K ﹤0.01% 2612

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BLRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its BioLineRX (BLRX) position steady in Q4 2019 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5327.

Ladenburg Thalmann Financial Services first reported a position in BLRX in Q4 2015 and has held it in 17 quarters since. The position peaked at $46K in Q3 2016. 12 funds tracked by Wall St. Rank hold BLRX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3 shares of BioLineRX worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its BioLineRX share count unchanged in Q4 2019.
  • BioLineRX made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5327 holding.
  • Ladenburg Thalmann Financial Services first reported a position in BioLineRX in Q4 2015 and has held it in 17 quarters since.
  • Ladenburg Thalmann Financial Services's BioLineRX position peaked at $46K in Q3 2016.
  • 12 funds tracked by Wall St. Rank held BioLineRX as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.